Publications

Stenting (Clinical)

 

  1. Schneider PA, Giasolli R, Ebner A, Virmani R, Granada JF.   Early experimental and clinical experience with a focal implant for lower extremity post-angioplasty dissection.  JACC Cardiovasc Interv. 2015 Feb;8(2):347-54. doi: 10.1016/j.jcin.2014.07.032.  PMID: 25700758
  2. Koppara T, Virmani R, Joner M. Optical coherence tomography surveillance following drug-eluting stent implantation.  Minerva Cardioangiol. 2015 Feb;63(1):59-74. Epub 2015 Jan 8.  PMID: 25566936
  3. Sanchez OD, Yahagi K, Koppara T, Virmani R, Joner M. The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view.  Med Devices (Auckl). 2014 Dec 30;8:37-45. doi: 10.2147/MDER.S50051. eCollection 2015. Review.  PMID: 25565907
  4. Zarpak R, Sanchez OD, Joner M, Guy LG, Leclerc G, Virmani R.  A novel “pro-healing” approach: the COMBO™ dual therapy stent from a pathological view.  Minerva Cardioangiol. 2015 Feb;63(1):31-43. Epub 2014 Nov 27.  PMID: 25502187
  5. Guagliumi G, Capodanno D, Saia F, Musumeci G, Tarantini G, Garbo R, Tumminello G, Sirbu V, Coccato M, Fineschi M, Trani C, De Benedictis M, Limbruno U, De Luca L, Niccoli G, Bezerra H, Ladich E, Costa M, Biondi Zoccai G, Virmani R; OCTAVIA Trial Investigators. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.  JACC Cardiovasc Interv. 2014 Sep;7(9):958-68. doi: 10.1016/j.jcin.2014.05.011. Epub 2014 Aug 13.  PMID: 25129664
  6. Nakano M, Virmani R. Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice.  Cardiovasc Interv Ther. 2015 Jan;30(1):1-11. doi: 10.1007/s12928-014-0281-5. Epub 2014 Jul 30.  PMID: 25074761
  7. Singla V, Virmani V, Modi M, Kalra N, Khandelwal N. Chronic rupture of abdominal aortic aneurysm with vertebral erosion: an uncommon but important cause of back pain.  Ann Vasc Surg. 2014 Nov;28(8):1931.e1-4. doi: 10.1016/j.avsg.2014.07.006. Epub 2014 Jul 11.  PMID: 25017777
  8. Habib A, Karmali V, John MC, Polavarapu R, Nakazawa G, Pachura K, Davis T, Kolodgie FD, Virmani R, Finn AV. Everolimus-eluting stents improve vascular response in a diabetic animal model.  Circ Cardiovasc Interv. 2014 Aug;7(4):526-32. doi: 10.1161/CIRCINTERVENTIONS.113.001023. Epub 2014 Jun 10.  PMID: 24915972
  9. Otsuka F, Pacheco E, Perkins LE, Lane JP, Wang Q, Kamberi M, Frie M, Wang J, Sakakura K, Yahagi K, Ladich E, Rapoza RJ, Kolodgie FD, Virmani R. Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.  Circ Cardiovasc Interv. 2014 Jun;7(3):330-42. doi: 10.1161/CIRCINTERVENTIONS.113.000990. Epub 2014 Jun 3.  PMID: 24895447
  10. Lane JP, Perkins LE, Sheehy AJ, Pacheco EJ, Frie MP, Lambert BJ, Rapoza RJ, Virmani R. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries.  JACC Cardiovasc Interv. 2014 Jun;7(6):688-95. doi: 10.1016/j.jcin.2013.11.024. Epub 2014 May 14. PMID: 24835327
  11. Nakano M, Yahagi K, Otsuka F, Sakakura K, Finn AV, Kutys R, Ladich E, Fowler DR, Joner M, Virmani R. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study.  J Am Coll Cardiol. 2014 Jun 17;63(23):2510-20. doi: 10.1016/j.jacc.2014.02.607. Epub 2014 Apr 23.  PMID: 24768883
  12. Steigen SE, Holm NR, Butt N, Maeng M, Otsuka F, Virmani R, Ladich E, Steigen TK. Clinical use of optical coherence tomography to identify angiographic silent stent thrombosis.  Scand Cardiovasc J. 2014 Jun;48(3):156-60. doi: 10.3109/14017431.2014.900185.  PMID: 24601754
  13. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, Kutys R, Ladich E, Finn AV, Kolodgie FD, Virmani R.   Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans.  Circulation. 2014 Jan 14;129(2):211-23. doi: 10.1161/CIRCULATIONAHA.113.001790. Epub 2013 Oct 25. PMID: 24163064
  14. Dani S, Costa RA, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A. First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels – results from the meriT-1 trial. EuroIntervention. 2013 Aug 22;9(4):493-500. doi: 10.4244/EIJV9I4A79.  PMID: 23965355
  15. Nakano M, Otsuka F, Yahagi K, Sakakura K, Kutys R, Ladich ER, Finn AV, Kolodgie FD, Virmani R. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics.  Eur Heart J. 2013 Nov;34(42):3304-13. doi: 10.1093/eurheartj/eht241. Epub 2013 Jul 3.  PMID: 23824827
  16. Farooq V, Serruys PW, Heo JH, Gogas BD, Onuma Y, Perkins LE, Diletti R, Radu MD, Räber L, Bourantas CV, Zhang Y, van Remortel E, Pawar R, Rapoza RJ, Powers JC, van Beusekom HM, Garcìa-Garcìa HM, Virmani R. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.  JACC Cardiovasc Interv. 2013 May;6(5):523-32. doi: 10.1016/j.jcin.2012.12.131. m PMID: 23702016
  17. Lemos PA, Farooq V, Takimura CK, Gutierrez PS, Virmani R, Kolodgie F, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom HM, Serruys PW.  Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.  EuroIntervention. 2013 May 20;9(1):148-56. doi: 10.4244/EIJV9I1A21.  PMID: 23685303
  18. Otsuka F, Nakano M, Sakakura K, Ladich E, Kolodgie FD, Virmani R. Unique demands of the femoral anatomy and pathology and the need for unique interventions  J Cardiovasc Surg (Torino). 2013 Apr;54(2):191-210. Review.  PMID: 23558655
  19. Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G, Kastrati A, Virmani R, Byrne RA, Joner M. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.  Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1376-83. doi: 10.1161/ATVBAHA.113.301227. Epub 2013 Mar 28.  PMID: 23539216
  20. Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap.  JACC Cardiovasc Imaging. 2013 Mar;6(3):283-7. doi: 10.1016/j.jcmg.2012.12.007.  PMID: 23473109
  21. Bekken JA, Vos JA, Aarts RA, de Vries JP, Fioole B. DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial. Trials. 2012 Nov 19;13:215. doi: 10.1186/1745-6215-13-215. PMID: 23164097
  22. Briguori C, Virmani R, Kolodgie F, Byrne RA, Steigerwald K, Orlowski M, Joner M. From bench to bedside: initial experience with the Primus drug-coated balloon catheter  Minerva Cardioangiol. 2012 Oct;60(5):507-15.  PMID: 23018430
  23. Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y. In-stent neoatherosclerosis: a final common pathway of late stent failure.  J Am Coll Cardiol. 2012 Jun 5;59(23):2051-7. doi: 10.1016/j.jacc.2011.10.909. Review.  PMID: 22651862
  24. Yazdani SK, Kolodgie FD, Virmani R. Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent.   Minerva Cardioangiol. 2012 Feb;60(1):11-21. Review.  PMID: 22322570
  25. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, Ladich ER, Kolodgie FD, Virmani R. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging.  JACC Cardiovasc Imaging. 2012 Jan;5(1):71-82. doi: 10.1016/j.jcmg.2011.09.015.  PMID: 22239896
  26. Milewski K, Tellez A, Aboodi MS, Conditt GB, Yi GH, Thim T, Stenoien M, McGregor JC, Gray WA, Virmani R, Granada JF, Kaluza GL.  Paclitaxel-iopromide coated balloon followed by “bail-out” bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.  EuroIntervention. 2011 Jul;7(3):362-8. doi: 10.4244/EIJV7I3A61.  PMID: 21729839
  27. Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R.  Autopsy validation study of the academic research consortium stent thrombosis definition.  JACC Cardiovasc Interv. 2011 May;4(5):554-9. doi: 10.1016/j.jcin.2011.01.011.  PMID: 21596329
  28. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R.  Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.  J Am Coll Cardiol. 2011 Jan 25;57(4):390-8. doi: 10.1016/j.jacc.2010.05.066.  PMID: 21251578
  29. Killer M, Kallmes D, Jones R, Ding Y, Vestal M, Hauser T, Virmani R, Cruise G. Long-term angiographic and histological results of a new hydrogel-containing filling coil in experimental rabbit aneurysms.  Minim Invasive Neurosurg. 2010 Jun;53(3):97-105. doi: 10.1055/s-0030-1252059. Epub 2010 Aug 31.  PMID: 20809449
  30. Vorpahl M, Virmani R, Ladich E, Finn AV. Vascular remodeling after coronary stent implantation.  Minerva Cardioangiol. 2009 Oct;57(5):621-8. Review.  PMID: 19838152
  31. Nakazawa G, Ladich E, Virmani R. Are drug-eluting stents safe?: Definitely! Or probably… possibly? Or maybe not yet….  Clin Pharmacol Ther. 2009 Aug;86(2):127-30. doi: 10.1038/clpt.2009.113. No abstract available.   PMID: 19621005
  32. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.  Circulation. 009 Jul 14;120(2):141-9, 1-2. doi: 10.1161/CIRCULATIONAHA.107.730010. Epub 2009 Jun 29.  PMID: 19564562
  33. Nakazawa G, Ladich E, Finn AV, Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury.  EuroIntervention. 2008 Aug;4 Suppl C:C7-10.  PMID: 19202684
  34. Nakazawa G, Finn AV, Kolodgie FD, Virmani R. A review of current devices and a look at new technology: drug-eluting stents.  Expert Rev Med Devices. 2009 Jan;6(1):33-42. doi: 10.1586/17434440.6.1.33. Review.  PMID: 19105778
  35. Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, Virmani R. Drug-eluting stent safety: findings from preclinical studies.  Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1379-91. doi: 10.1586/14779072.6.10.1379. Review.  PMID: 19018691
  36. Schwartz RS, Edelman E, Virmani R, Carter A, Granada JF, Kaluza GL, Chronos NA, Robinson KA, Waksman R, Weinberger J, Wilson GJ, Wilensky RL. Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation.  Circ Cardiovasc Interv. 2008 Oct;1(2):143-53. doi: 10.1161/CIRCINTERVENTIONS.108.789974.  PMID: 20031669
  37. Cooper CJ, Haller ST, Colyer W, Steffes M, Burket MW, Thomas WJ, Safian R, Reddy B, Brewster P, Ankenbrandt MA, Virmani R, Dippel E, Rocha-Singh K, Murphy TP, Kennedy DJ, Shapiro JI, D’Agostino RD, Pencina MJ, Khuder S.  Embolic protection and platelet inhibition during renal artery stenting.  Circulation. 2008 May 27;117(21):2752-60. doi: 10.1161/CIRCULATIONAHA.107.730259. Epub 2008 May 19.  PMID: 18490527
  38. Diethrich EB, Pauliina Margolis M, Reid DB, Burke A, Ramaiah V, Rodriguez-Lopez JA, Wheatley G, Olsen D, Virmani R. Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study.  J Endovasc Ther. 2007 Oct;14(5):676-86. PMID: 17924734
  39. Ribichini F, Pugno F, Ferrero V, Wijns W, Vacca G, Vassanelli C, Virmani R. Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts.  Clin Sci (Lond). 2008 Feb;114(3):211-20.  PMID: 17848140
  40. Sangiorgi G, Melzi G, Agostoni P, Cola C, Clementi F, Romitelli P, Virmani R, Colombo A. Engineering aspects of stents design and their translation into clinical practice.  Ann Ist Super Sanita. 2007;43(1):89-100. Review.  PMID: 17536159
  41. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.  Circulation. 2007 May 8;115(18):2435-41. Epub 2007 Apr 16.  PMID: 17438147
  42. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.  Circulation. 2007 Feb 27;115(8):1051-8. Review.  PMID: 17325255
  43. Fischell TA, Fischell DR, Fischell RE, Virmani R, DeVries JJ, Krucoff MW. Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model.  J Am Coll Cardiol. 2006 Dec 5;48(11):2306-14. Epub 2006 Nov 13.  PMID: 17161264
  44. Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Gold HK, Virmani R. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.  Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):182-9. Epub 2006 Oct 26.   PMID: 17068283
  45. Waksman R, Pakala R, Baffour R, Hellinga D, Seabron R, Kolodgie F, Virmani R. Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries.  Cardiovasc Revasc Med. 2006 Jul-Sep;7(3):179-84.  PMID: 16945826
  46. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, Cremonesi A, Fairman R, Walker G, Verta P, Popma J, Virmani R, Cohen DJ; ARCHeR Trial Collaborators. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results.  J Vasc Surg. 2006 Aug;44(2):258-68. Erratum in: J Vasc Surg. 2007 Jan;45(1):226.   PMID: 16890850
  47. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.  J Am Coll Cardiol. 2006 Jul 4;48(1):193-202. Epub 2006 May 5.  PMID: 16814667
  48. Stefanadis C, Toutouzas K, Stefanadi E, Kolodgie F, Virmani R, Kipshidze N. First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model.  Hellenic J Cardiol. 2006 Jan-Feb;47(1):7-10.  PMID: 16532709
  49. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn.  J Am Coll Cardiol. 2004 Oct 6;44(7):1373-85. Review.  PMID: 15464316 Free Article
  50. Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den Heijer P, de Feyter P, Buszman P, Schömig A, Marco J, Polonski L, Thuesen L, Zeiher AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L, Virmani R; ACTION investigators. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.  J Am Coll Cardiol. 2004 Oct 6;44(7):1363-7.  PMID: 15464314
  51. Kay IP, Ligthart JM, Virmani R, van Beusekom HM, Kozuma K, Carter AJ, Sianos G, van der Giessen WJ, Wardeh AJ, de Feyter PJ, Serruys PW. The black hole: echolucent tissue observed following intracoronary radiation. Int J Cardiovasc Intervent. 2003;5(3):137-42.  PMID: 12959730
  52. Oesterle SN, Reifart N, Hayase M, Hauptmann E, Low R, Erbel R, Haude M, Dirsch O, Schuler GC, Virmani R, Yeung AC.  Catheter-based coronary bypass: a development update.  Catheter Cardiovasc Interv. 2003 Feb;58(2):212-8.  PMID: 12552547
  53. Virmani R, Kolodgie FD, Farb A, Lafont A.   Drug eluting stents: are human and animal studies comparable?  Heart. 2003 Feb;89(2):133-8. Review.  PMID: 12527658
  54. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD, Colombo A.  Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.  Circulation. 2002 Nov 19;106(21):2649-51.  PMID: 12438288
  55. Kolodgie FD, John M, Khurana C, Farb A, Wilson PS, Acampado E, Desai N, Soon-Shiong P, Virmani R. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel.  Circulation. 2002 Sep 3;106(10):1195-8.  PMID: 12208792
  56. Virmani R, Farb A, Kolodgie FD. Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences.  Herz. 2002 Feb;27(1):1-6. Review.  PMID: 11951791
  57. Taylor AJ, Gorman PD, Kenwood B, Hudak C, Tashko G, Virmani R. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model.  Catheter Cardiovasc Interv. 2001 Jul;53(3):420-5.  PMID: 11458427
  58. Virmani R, Farb A, Carter AJ, Jones RM. Pathology of radiation-induced coronary artery disease in human and pig. Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):98-101. Review.  PMID: 11272363
  59. Carter AJ, Lee DP, Suzuki T, Bailey L, Lansky A, Jones R, Virmani R. Experimental evaluation of a short transitional edge protection balloon for intracoronary stent deployment.  Catheter Cardiovasc Interv. 2000 Sep;51(1):112-9.  PMID: 10973033
  60. Kim WH, Hong MK, Virmani R, Kornowski R, Jones R, Leon MB.  Histopathologic analysis of in-stent neointimal regression in a porcine coronary model.  Coron Artery Dis. 2000 May;11(3):273-7.  PMID: 10832562
  61. Thomas WJ, Laird JR, Bailey L, Hoopes TG, Hillhouse R, Scott D, Jones R, Virmani R, Carter AJ. Experimental Results with the Multi-Linkª Stent in a Porcine Model.  J Invasive Cardiol. 1997 Sep;9(7):453-460. PMID: 10762942
  62. Carter AJ, Scott D, Rahdert D, Bailey L, De Vries J, Ayerdi K, Turnlund T, Jones R, Virmani R, Fischell TA. Stent design favorably influences the vascular response in normal porcine coronary arteries.  J Invasive Cardiol. 1999 Mar;11(3):127-34.  PMID: 10745499
  63. Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, McQueen C, Kolodgie FD, Buller E, Dodek A, Mancini GB, Oesterle S. Retrieval and analysis of particulate debris after saphenous vein graft intervention.  J Am Coll Cardiol. 1999 Aug;34(2):468-75.  PMID: 1044016
  64. Virmani R, Farb A, Carter AJ, Jones RM. Comparative pathology: radiation-induced coronary artery disease in man and animals  Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):163-72. Review.  PMID: 10406688
  65. Kornowski R, Hong MK, Virmani R, Jones R, Vodovotz Y, Leon MB. Granulomatous ‘foreign body reactions’ contribute to exaggerated in-stent restenosis.  Coron Artery Dis. 1999;10(1):9-14.  PMID: 10196682
  66. Oesterle SN, Whitbourn R, Fitzgerald PJ, Yeung AC, Stertzer SH, Dake MD, Yock PG, Virmani R. The stent decade: 1987 to 1997. Stanford Stent Summit faculty.  Am Heart J. 1998 Oct;136(4 Pt 1):578-99. Review.  PMID: 9778060
  67. Carter AJ, Laird JR, Bailey LR, Hoopes TG, Farb A, Fischell DR, Fischell RE, Fischell TA, Virmani R. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. Circulation. 1996 Nov 15;94(10):2364-8. PMID: 8921774